Plain-English translation of NCT06747039 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is following patients with fibromyalgia who are being prescribed Avextra 10/10, a standardized cannabis extract containing equal amounts of THC and CBD. Researchers want to track how this medication affects your pain, fatigue, sleep, mood, and overall quality of life over 12 weeks. This study is observational, meaning the doctors are carefully documenting your experience rather than randomly assigning you to different treatment groups.
Fibromyalgia causes widespread pain and exhaustion that can be very difficult to treat, and many people find that standard treatments don't work or cause unwanted side effects. This study exists to understand whether this medication can help people like you feel better when conventional options have fallen short.
You likely qualify if…
You likely don't qualify if…
You would be taking the medication as prescribed by your doctor and visiting the research clinic at set intervals—at 4 weeks, 8 weeks, and 12 weeks—to complete questionnaires about your pain, fatigue, sleep quality, mood, and overall wellbeing. The study lasts 12 weeks total, and researchers will also track any side effects or reasons you might need to stop the medication. This is an observational study, so your role is to share your honest experience and complete the assessment forms at each visit.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Italy
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Enrollment target
~38 participants
Started
December 2024
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Greta Pellegrino, Medical Doctor
IRCCS Ospedale Galeazzi Sant'Ambrogio
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.